PLMD Polymedica Corp (MM)

PolyMedica Corporation (NASDAQ: PLMD) today announced that its wholly owned subsidiary, Liberty Healthcare Group, Inc. (�Liberty�), the nation's largest mail order diabetes supply company, has entered into a multi-year National Strategic Partnership agreement with the American Diabetes Association (ADA). As a National Strategic Partner, Liberty will support the ADA�s �I Decide To Fight DiabetesSM" campaign. The �I Decide To Fight Diabetes� campaign is focused on inspiring people to live healthier lives and to make better choices when it comes to preventing and managing diabetes. The campaign is focused on raising funds to support the mission of the American Diabetes Association � to prevent and cure diabetes and to improve the lives of all people affected by diabetes as well as to help people express themselves as part of a movement to stem the tide against the disease. People with diabetes, their friends and families, as well as those at risk, are encouraged to display their commitment by wearing an �I Decide To Fight Diabetes� charm, t-shirt, or other item available at the ADA�s web site, www.diabetes.org/IDecide. �By becoming a National Charter Sponsor of the �I Decide to Fight Diabetes� campaign, Liberty is helping to amplify the voice of the diabetes cause,��stated Patrick T. Ryan, Chief Executive Officer of PolyMedica. �Liberty�s team members are proud to support the American Diabetes Association in this critical fight against diabetes.� Liberty will help to further the mission of the ADA and an important Liberty priority by offering support for the �I Decide to Fight Diabetes� campaign, which seeks to inspire and empower patients in leading healthier lives. Liberty patients will benefit from access to the ADA�s resources. �The ADA needs more champions in the fight against diabetes, and we appreciate Liberty�s commitment to people living with diabetes and their support of the ADA�s mission,��said Larry�C. Deeb, MD, ADA�s President, Medicine & Science. Today, diabetes is America�s number one health threat: Nearly 21 million adults and children have diabetes One-third of them (6.2 million) don't know they have the disease One in three Americans born in 2000 will develop diabetes in their lifetime if nothing is done to stem the tide Diabetes kills more people than breast cancer and AIDS combined For more information on Liberty, go to www.libertymedical.com. For more information on the American Diabetes Association and the �I Decide To Fight Diabetes� campaign, go to www.diabetes.org/IDecide. About PolyMedica Corporation and Liberty Healthcare Group For more than a decade, Liberty has been the nation�s largest provider of blood glucose testing supplies and related services to people with diabetes and today serves more than 943,000 active diabetes patients. Liberty also offers a full service pharmacy to meet patients� medication needs and provides patient education to help its patients better manage their health conditions. Through proactive patient outreach, convenient home delivery and administrative support, Liberty makes it simple for patients to obtain the supplies and medications they need, while encouraging compliance with physicians� orders. More information about Liberty and PolyMedica Corporation can be found at www.libertymedical.com and www.polymedica.com. About ADA The American Diabetes Association is the nation�s premier voluntary health organization supporting diabetes research, information and advocacy. Founded in 1940, the Association has offices in every region providing services to hundreds of communities. Its mission is to prevent and cure diabetes and approve the lives of all people affected by diabetes. For more information, please visit www.diabetes.org or call 1-800-DIABETES (1-800-342-2382). Information from both these sources is available in English and Spanish. This press release contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, rules and regulations promulgated under the Act, unanticipated changes in Medicare reimbursement, successful participation in new reimbursement programs, outcomes of government reviews, inquiries, investigations and related litigation, continued compliance with government regulations, fluctuations in customer demand, management of rapid growth, competition from other healthcare product vendors, timing and acceptance of new product introductions, general economic conditions, geopolitical events and regulatory changes, as well as other especially relevant risks detailed in PolyMedica�s filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the period ended March 31, 2007, and Quarterly Reports on Form 10-Q for the periods ended June 30, 2006, September 30, 2006 and December 31, 2006. The information set forth herein should be read in light of such risks. PolyMedica assumes no obligation to update the information contained in this press release.